A decade of hospital surveillance in Mexico points to species turnover as the main driver of rising fluconazole non-susceptibility, with Nakaseomyces glabratus increasing over time. The analysis links antifungal resistance trends less to single-gene change and more to the changing composition of circulating Candida species. The work underscores that resistance surveillance may need to track epidemiology at the species level, not just susceptibility phenotypes, particularly in settings where treatment practices shape future fungal ecology.
Get the Daily Brief